What is the appropriate intramuscular dose of Serenace (haloperidol) for an adult presenting with acute irritability and psychosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intramuscular Haloperidol Dosing for Acute Irritability and Psychosis in Adults

For acute irritability and psychosis in adults, administer intramuscular haloperidol 5 mg as the initial dose, which can be repeated every 4-6 hours as needed, with a maximum daily dose of 40 mg. 1

Evidence-Based Dosing Algorithm

The 5 mg intramuscular dose represents the standard evidence-based approach supported by multiple Class II studies comparing haloperidol to benzodiazepines and other antipsychotics 1. This dose has been consistently used across clinical trials and demonstrates:

  • Significant efficacy in controlling acute agitation and psychosis
  • Established safety profile when used appropriately
  • Ability to be repeated at 4-6 hour intervals based on clinical response 1

Dosing Considerations by Clinical Context

For undifferentiated acute agitation:

  • Initial dose: 5 mg IM
  • Can repeat every 4-6 hours as clinically indicated
  • Maximum 40 mg/day 1

For known psychotic illness with severe agitation:

  • Same 5 mg IM initial dose
  • Studies support doses ranging from 2-5 mg, with 5 mg showing superior efficacy to lower doses 2
  • Historical data from 1974 demonstrated that 5 mg and 2 mg doses were significantly superior to 1 mg doses 2

Combination therapy option:

  • Haloperidol 5 mg IM + lorazepam 2 mg IM produces more rapid sedation than monotherapy 3
  • This combination is supported by Level C recommendations and may be preferred when rapid control is essential 1

Important Safety Caveats

QTc prolongation risk: All antipsychotics at maximum recommended daily dosages prolong QTc interval, though typically not exceeding 500 ms 1. Consider baseline ECG in patients with cardiac risk factors.

Extrapyramidal symptoms (EPS): Haloperidol carries higher risk of movement disorders compared to atypical antipsychotics 4. Have anticholinergic medications (e.g., benztropine, diphenhydramine) readily available. Studies show EPS can be completely controlled with antiparkinson drugs 2.

Avoid in anticholinergic or sympathomimetic toxicity: Haloperidol's anticholinergic side effects can worsen agitation in these specific poisoning scenarios 1.

Alternative Considerations

While haloperidol 5 mg IM remains the gold standard with the strongest evidence base 1, newer evidence suggests:

  • Ziprasidone 20 mg IM shows superior efficacy and better tolerability (fewer movement disorders) when dosed every 4-6 hours 4
  • Droperidol 5 mg provides faster sedation than haloperidol but carries FDA black box warning for dysrhythmias 1
  • Lorazepam 2-4 mg IM alone is equally effective as haloperidol for undifferentiated agitation 1

Clinical Pearls

The 5 mg dose strikes the optimal balance between efficacy and safety. Lower doses (1-2 mg) show reduced efficacy 2, while the 5 mg dose has been validated across decades of research and multiple clinical settings. Haloperidol has by far the best evidence base among conventional antipsychotics for treatment of agitation 1, with 20 double-blind studies since 1973 supporting its use.

For patients requiring rapid control within 3 hours, studies demonstrate almost complete remission of cardinal psychotic symptoms (thought disorder, hallucinations, delusions) is achievable with repeated IM haloperidol dosing 5.

Related Questions

What is the recommended intramuscular (IM) dosage of haloperidol for adults (including elderly or patients with hepatic or renal impairment) and for children aged 5 years and older?
What is the recommended intramuscular dosing of haloperidol (Haldol) with lorazepam and diphenhydramine (Benadryl) for rapid control of severe agitation in acute mania?
Should a scheduled afternoon dose of lorazepam (Ativan) 0.25 mg be added for a 79‑year‑old woman with dementia, psychosis, depression, and anxiety who is already receiving haloperidol (Haldol) 5 mg twice daily, olanzapine 20 mg daily, haloperidol 2 mg as needed, and lorazepam 0.25 mg as needed?
Which medication is most appropriate for rapid control of acute psychosis and agitation in a patient with schizophrenia: haloperidol, lorazepam (Ativan), diphenhydramine (Benadryl), clozapine, or supportive care?
What intramuscular (IM) dose of haloperidol (Haldol) is recommended for acute agitation in adults, and how should dosing be modified for elderly patients?
What is the recommended therapy for an acneiform exanthem?
What pre‑procedure preparation is required before an MRI‑fusion prostate biopsy?
What is the therapeutic dose of enoxaparin (Lovenox) for an adult, and how should the dose be adjusted for renal impairment or obesity?
Should rabies immunoglobulin (RIG) be given for a cat scratch abrasion along with the rabies vaccine?
Should rabies immunoglobulin be given for a cat scratch abrasion without saliva contamination when the cat is healthy and can be observed?
What is the appropriate diet and nutritional management for an adult patient with acute necrotizing pancreatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.